|
gptkbp:instance_of
|
gptkb:DJ
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Ion_PGM
gptkb:DRAGEN_Bio-IT_Platform
gptkb:Illumina_Tru_Seq_RNA_Library_Prep_Kit
gptkb:Illumina_Tru_Seq_RNA_Library_Prep_Kit_v3
gptkb:Illumina_Tru_Seq_RNA_Library_Prep_Kit_v4
gptkb:Illumina_Tru_Seq_RNA_Library_Prep_Kit_v4.5
gptkb:Illumina_Tru_Seq_RNA_Library_Prep_Kit_v5
gptkb:Illumina_Tru_Seq_Targeted_RNA_Expression_Kit
|
|
gptkbp:acquisition
|
gptkb:Grail,_Inc.
|
|
gptkbp:application
|
personalized medicine
clinical diagnostics
genomic research
transcriptomics
metagenomics
agricultural genomics
|
|
gptkbp:employees
|
over 7,000
|
|
gptkbp:features
|
high accuracy
high throughput
user-friendly software
low cost per base
multiplexing capability
integrated workflow
flexible read lengths
|
|
gptkbp:headquarters
|
gptkb:San_Diego,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Illumina sequencers
|
|
gptkbp:input_output
|
gptkb:FASTQ
gptkb:BAM
VCF
|
|
gptkbp:length
|
up to 300 base pairs
|
|
gptkbp:manufacturer
|
gptkb:Illumina,_Inc.
|
|
gptkbp:market
|
global market leader
|
|
gptkbp:partnership
|
pharmaceutical companies
biotechnology firms
various academic institutions
|
|
gptkbp:platform
|
gptkb:Mi_Seq
gptkb:Nova_Seq
gptkb:Next_Seq
Hi Seq
|
|
gptkbp:production_company
|
gptkb:Company
|
|
gptkbp:regulatory_compliance
|
FDA approved
CE marked
|
|
gptkbp:revenue
|
over $3 billion (2020)
|
|
gptkbp:seed_dispersal
|
sequencing by synthesis
|
|
gptkbp:supports
|
DNA sequencing
whole genome sequencing
RNA sequencing
targeted sequencing
single-cell sequencing
exome sequencing
metagenomic sequencing
amplicon sequencing
|
|
gptkbp:technology
|
next-generation sequencing
|
|
gptkbp:type
|
paired-end
single-end
|
|
gptkbp:year_created
|
gptkb:2006
|